Resultats de la cerca - Matthew Onsum

  • Mostrar 1 - 6 resultats de 6
Refinar resultats
  1. 1
    A Mathematical Model for Neutrophil Gradient Sensing and Polarization

    A Mathematical Model for Neutrophil Gradient Sensing and Polarization per Matthew Onsum, Christopher V. Rao

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B

    HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B per Daniel C. Kirouac, Jinyan Du, Johanna Lahdenranta, Matthew Onsum, Ulrik B. Nielsen, Birgit Schoeberl, Charlotte F. McDonagh

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients

    Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients per Matthew Onsum, Elena Geretti, Violette Paragas, Arthur J. Kudla, Sharon Moulis, Lia Luus, Thomas J. Wickham, Charlotte F. McDonagh, Gavin MacBeath, Bart S. Hendriks

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma

    Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma per Deepa Jagadeesh, Steve Horwitz, Nancy L. Bartlett, Hyun Soo Kim, Eric D. Jacobsen, Madeleine Duvic, Meredith Little, William L. Trepicchio, Keenan Fenton, Matthew Onsum, Julie Lisano, Ranjana H. Advani

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation

    An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation per Birgit Schoeberl, Anthony C. Faber, Danan Li, Mei‐Chih Liang, Katherine Crosby, Matthew Onsum, Olga Burenkova, Emily Pace, Zandra E. Walton, Lin Nie, Aaron Fulgham, Youngchul Song, Ulrik B. Nielsen, Jeffrey A. Engelman, Kwok‐Kin Wong

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Response to brentuximab vedotin versus physician’s choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis

    Response to brentuximab vedotin versus physician’s choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis per Youn H. Kim, H. Miles Prince, Sean Whittaker, Sarah McCue Horwitz, Madeleine Duvic, Oliver Bechter, José Antônio Sanches, Rudolf Stadler, Julia Scarisbrick, Pietro Quaglino, Pier Luigi Zinzani, Pascal Wolter, Herbert Eradat, Lauren Pinter‐Brown, Pablo L. Ortiz‐Romero, Oleg E. Akilov, Judith Trotman, Kerry Taylor, Michael Weichenthal, Jan Walewski, David C. Fisher, Marise McNeeley, Alejandro A. Gru, Lisa Brown, Maria Corinna Palanca-Wessels, Julie Lisano, Matthew Onsum, Veronica Bunn, Meredith Little, William L. Trepicchio, Reinhard Dummer

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: